Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Targeted treatment of solid tumors and hematologic malignancies.
Advanced Prostate Cancer and Premenopausal Hormone-Receptor Positive Breast Cancer.
Approved for use in oncology care according to FDA-approved indications.
Approved for use in oncology care according to FDA-approved indications.
PSMA-positive Metastatic Castration-Resistant Prostate Cancer, Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs), and Pheochromocytoma.
PSMA-positive Metastatic Castration-Resistant Prostate Cancer, Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs), and Pheochromocytoma.
PSMA-positive Metastatic Castration-Resistant Prostate Cancer, Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs), and Pheochromocytoma.
Approved for use in oncology care according to FDA-approved indications.
Maintenance treatment of adult patients with deleterious or suspected deleterious germline or somatic BRCA-mutated advanced ovarian, breast, pancreatic, and prostate cancer.
Advanced solid tumors and hematologic malignancies with matching genomic alterations.